Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, June 22, 2024 | Back issues
Courthouse News Service Courthouse News Service

Biopharma Merger

WILMINGTON, Del. - Shareholders say Inhibitex, a biopharma company, is selling itself too cheaply to Bristol-Myers Squibb, for $2.5 billion or $26 a share.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.